Insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Asian patients with type 2 diabetes inadequately controlled on basal or pre-/self-mixed insulin: A 26-week, randomised, treat-to-target trial

Title
Insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Asian patients with type 2 diabetes inadequately controlled on basal or pre-/self-mixed insulin: A 26-week, randomised, treat-to-target trial
Authors
Keywords
Insulin degludec, Insulin aspart, Type 2 diabetes, HbA, 1c
Journal
DIABETES RESEARCH AND CLINICAL PRACTICE
Volume 107, Issue 1, Pages 139-147
Publisher
Elsevier BV
Online
2014-10-14
DOI
10.1016/j.diabres.2014.09.026

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation